Topological modification of interleukin-2 and application of interleukin-2 as autoimmune disease medicine

The invention discloses topological transformation of interleukin-2 and application of the interleukin-2 as an autoimmune disease medicine. According to the invention, the interleukin-2 is subjected to topological transformation, so that the interleukin-2 with a cyclic or isohydrocarbon topological...

Full description

Saved in:
Bibliographic Details
Main Authors HE JING, XIAO XIAN, TIAN XIBAO, ZHANG WENBIN, LI ZHANGUO, FENG RUILING, FANG JING
Format Patent
LanguageChinese
English
Published 07.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention discloses topological transformation of interleukin-2 and application of the interleukin-2 as an autoimmune disease medicine. According to the invention, the interleukin-2 is subjected to topological transformation, so that the interleukin-2 with a cyclic or isohydrocarbon topological structure of targeted activated Treg is obtained. The affinity of the interleukin-2 with the cyclic or Soxhlet-hydrocarbon structure and a receptor is not changed, the half-life period of the medicine can be prolonged, the stability can be enhanced, the dosage of long-term medication and the medication frequency can be reduced, and the effect of inhibiting immunity can be achieved. As a long-acting immunosuppressor, the interleukin-2 topological transformation protein disclosed by the invention is beneficial to treatment of various autoimmune diseases. 本发明公开了白细胞介素-2的拓扑改造及其作为自身免疫病药物的应用。本发明对白细胞介素-2进行拓扑改造,获得了靶向性激活Treg的环状或索烃拓扑结构的白细胞介素-2。环状或索烃结构的白细胞介素-2不改变其与受体的亲和性,同时可以延长药物的半衰期,增强稳定性,减少长期用药的剂量和用药次数,发挥抑制免疫的效果。本发明的白细胞介素-2拓
Bibliography:Application Number: CN202310827760